{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:23:48Z","timestamp":1785522228285,"version":"3.56.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08274-z","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T14:04:26Z","timestamp":1779977066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["YY1-induced upregulation of DLGAP5 promotes tumor progression in lung adenocarcinoma via Wnt\/\u03b2-catenin\/EMT pathway"],"prefix":"10.1186","volume":"24","author":[{"given":"Jiahe","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunbao","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"8274_CR1","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1200\/JCO.21.00471","volume":"39","author":"JJ Griggs","year":"2021","unstructured":"Griggs JJ, Bohlke K, Balaban EP, Dignam JJ, Hall ET, Harvey RD, Hecht DP, Klute KA, Morrison VA, Pini TM, Rosner GL, Runowicz CD, Shayne M, Sparreboom A, Turner S, Zarwan C. Lyman, Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update. J Clin oncology: official J Am Soc Clin Oncol. 2021;39:2037\u201348.","journal-title":"J Clin oncology: official J Am Soc Clin Oncol"},{"key":"8274_CR2","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1111\/ans.16084","volume":"90","author":"JS Wormald","year":"2020","unstructured":"Wormald JS, Oberai T, Branford-White H, Johnson LJ. Design and establishment of a cancer registry: a literature review. ANZ J Surg. 2020;90:1277\u201382.","journal-title":"ANZ J Surg"},{"key":"8274_CR3","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1177\/03009858221092017","volume":"59","author":"LJ Schlein","year":"2022","unstructured":"Schlein LJ, Thamm DH. Review: NF-kB activation in canine cancer. Vet Pathol. 2022;59:724\u201332.","journal-title":"Vet Pathol"},{"key":"8274_CR4","doi-asserted-by":"crossref","unstructured":"Posner MG. Multimerin-1 and cancer: a review. Biosci Rep. 2022;42.","DOI":"10.1042\/BSR20211248"},{"key":"8274_CR5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/path.5902","volume":"257","author":"E Gadaleta","year":"2022","unstructured":"Gadaleta E, Thorn GJ, Ross-Adams H, Jones LJ, Chelala C. Field cancerization in breast cancer. J Pathol. 2022;257:561\u201374.","journal-title":"J Pathol"},{"key":"8274_CR6","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1002\/jcb.30173","volume":"123","author":"M Kulbay","year":"2022","unstructured":"Kulbay M, Paimboeuf A, Ozdemir D, Bernier J. Review of cancer cell resistance mechanisms to apoptosis and actual targeted therapies. J Cell Biochem. 2022;123:1736\u201361.","journal-title":"J Cell Biochem"},{"key":"8274_CR7","doi-asserted-by":"publisher","first-page":"108302","DOI":"10.1016\/j.pharmthera.2022.108302","volume":"240","author":"H Liu","year":"2022","unstructured":"Liu H, Dilger JP, Lin J. A pan-cancer-bioinformatic-based literature review of TRPM7 in cancers. Pharmacol Ther. 2022;240:108302.","journal-title":"Pharmacol Ther"},{"key":"8274_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13041-017-0324-9","volume":"10","author":"AH Rasmussen","year":"2017","unstructured":"Rasmussen AH, Rasmussen HB, Silahtaroglu A. The DLGAP family: neuronal expression, function and role in brain disorders. Mol Brain. 2017;10:43.","journal-title":"Mol Brain"},{"key":"8274_CR9","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.neuron.2008.10.014","volume":"60","author":"P Steiner","year":"2008","unstructured":"Steiner P, Higley MJ, Xu W, Czervionke BL, Malenka RC, Sabatini BL. Destabilization of the postsynaptic density by PSD-95 serine 73 phosphorylation inhibits spine growth and synaptic plasticity. Neuron. 2008;60:788\u2013802.","journal-title":"Neuron"},{"key":"8274_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0090-4295(02)01672-2","volume":"60","author":"AW Chiu","year":"2002","unstructured":"Chiu AW, Huang YL, Huan SK, Wang YC, Ju JP, Chen MF, Chou CK. Potential molecular marker for detecting transitional cell carcinoma. Urology. 2002;60:181\u20135.","journal-title":"Urology"},{"key":"8274_CR11","doi-asserted-by":"crossref","unstructured":"Zhang Q, Wang Y, Xue F. ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG may serve as diagnostic and prognostic biomarkers in endometrial carcinoma, Genetics Research. 2022;2022:3217248.","DOI":"10.1155\/2022\/3217248"},{"key":"8274_CR12","doi-asserted-by":"crossref","unstructured":"Zhou D, Wang M, Zhang Y, Wang K, Zhao M, Wang Y, Wang X, Yu R, Zhou X. Screening and identification of LMNB1 and DLGAP5, two key biomarkers in gliomas. Biosci Rep. 2021;41.","DOI":"10.1042\/BSR20210231"},{"key":"8274_CR13","doi-asserted-by":"crossref","unstructured":"Shi M, Guo H, Bai Y, Niu J, Niu X, Sun K, Chen Y. Upregulated mitosis-associated genes CENPE, CENPF, and DLGAP5 predict poor prognosis and chemotherapy resistance of Acute Myeloid Leukemia. Cancer biomarkers: section A of Disease markers. 2022;35:11\u201325.","DOI":"10.3233\/CBM-203170"},{"key":"8274_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12967-024-04910-8","volume":"22","author":"M Chen","year":"2024","unstructured":"Chen M, Zhang S, Wang F, He J, Jiang W, Zhang L. DLGAP5 promotes lung adenocarcinoma growth via upregulating PLK1 and serves as a therapeutic target. J translational Med. 2024;22:209.","journal-title":"J translational Med"},{"key":"8274_CR15","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41388-023-02932-y","volume":"43","author":"F Zhou","year":"2024","unstructured":"Zhou F, Deng Z, Shen D, Lu M, Li M, Yu J, Xiao Y, Wang G, Qian K, Ju L, Wang X. DLGAP5 triggers proliferation and metastasis of bladder cancer by stabilizing E2F1 via USP11. Oncogene. 2024;43:594\u2013607.","journal-title":"Oncogene"},{"key":"8274_CR16","doi-asserted-by":"crossref","unstructured":"Huang J, Zheng M, Li Y, Xu D, Tian D. DLGAP5 promotes gallbladder cancer migration and tumor-associated macrophage M2 polarization by activating cAMP. Cancer Immunology, Immunotherapy. 2023;72:3203\u201316.","DOI":"10.1007\/s00262-023-03484-6"},{"key":"8274_CR17","doi-asserted-by":"crossref","unstructured":"Li Y, Wei J, Sun Y, Zhou W, Ma X, Guo J, Zhang H, Jin T. DLGAP5 regulates the proliferation, migration, invasion, and cell cycle of breast cancer cells via the JAK2\/STAT3 signaling axis. Int J Mol Sci. 2023;24.","DOI":"10.3390\/ijms242115819"},{"key":"8274_CR18","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/tox.23720","volume":"38","author":"R Chen","year":"2023","unstructured":"Chen R, Liu J, Hu J, Li C, Liu Y, Pan W. DLGAP5 knockdown inactivates the Wnt\/\u03b2-catenin signal to repress endometrial cancer cell malignant activities. Environ Toxicol. 2023;38:685\u201393.","journal-title":"Environ Toxicol"},{"key":"8274_CR19","doi-asserted-by":"crossref","unstructured":"Wei X, Li X, Hu S, Cheng J, Cai R. Regulation of ferroptosis in lung adenocarcinoma. Int J Mol Sci. 2023;24.","DOI":"10.20944\/preprints202309.0765.v1"},{"key":"8274_CR20","doi-asserted-by":"crossref","unstructured":"Tang X, Ren H, Guo M, Qian J, Yang Y, Gu C. Review on circular RNAs and new insights into their roles in cancer. Computational and Structural Biotechnology Journal. 2021;19:910\u201328.","DOI":"10.1016\/j.csbj.2021.01.018"},{"key":"8274_CR21","doi-asserted-by":"crossref","unstructured":"Song Y, Kelava L, Kiss I. MiRNAs in lung adenocarcinoma: role, diagnosis, prognosis, and therapy. Int J Mol Sci. 2023;24.","DOI":"10.3390\/ijms241713302"},{"key":"8274_CR22","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.molmed.2019.04.012","volume":"25","author":"V Relli","year":"2019","unstructured":"Relli V, Trerotola M, Guerra E, Alberti S. Abandoning the Notion of Non-Small Cell Lung Cancer. Trends Mol Med. 2019;25:585\u201394.","journal-title":"Trends Mol Med"},{"key":"8274_CR23","first-page":"95","volume-title":"LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K\/AKT\/MYC pathway","author":"C Wei","year":"2019","unstructured":"Wei C, Dong X, Lu H, Tong F, Chen L, Zhang R, Dong J, Hu Y, Wu G, Dong X. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K\/AKT\/MYC pathway. Volume 38. Journal of experimental & clinical cancer research: CR; 2019. p. 95."},{"key":"8274_CR24","doi-asserted-by":"crossref","unstructured":"Zarif TE, Meador CB, Qiu X, Seo JH, Davidsohn MP, Savignano H, Lakshminarayanan G, McClure HM, Canniff J, Fortunato B, Li R, Banwait MK, Semaan K, Eid M, Long H, Hung YP, Mahadevan NR, Barbie DA, Oser MG, Piotrowska Z, Choueiri TK, Baca SC, Hata AN, Freedman ML, Berchuck JE. Detecting small cell transformation in patients with advanced EGFR mutant lung adenocarcinoma through epigenomic cfDNA profiling. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research. 2024;30:3798\u2013811.","DOI":"10.1158\/1078-0432.CCR-24-0466"},{"key":"8274_CR25","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/s41419-024-07226-z","volume":"15","author":"L Xiao","year":"2024","unstructured":"Xiao L, Li Q, Chen S, Huang Y, Ma L, Wang Y, Chen J, Zhang J, Liu A, Yuan X, Liu Y, Liu B. ADAMTS16 drives epithelial-mesenchymal transition and metastasis through a feedback loop upon TGF-\u03b21 activation in lung adenocarcinoma. Cell Death Dis. 2024;15:837.","journal-title":"Cell Death Dis"},{"key":"8274_CR26","doi-asserted-by":"crossref","unstructured":"Han M, Wan F, Xiao B, Du J, Peng C, Peng F. Cell components of tumor microenvironment in lung adenocarcinoma: promising targets for small-molecule compounds. Chin Med J. 2024.","DOI":"10.1097\/CM9.0000000000003341"},{"key":"8274_CR27","doi-asserted-by":"publisher","first-page":"1275957","DOI":"10.3389\/fimmu.2023.1275957","volume":"14","author":"J Zeng","year":"2023","unstructured":"Zeng J, Ding X, Ding J, Wang X. Histological transformation into SCLC: An important resistance mechanism of NSCLC upon immunotherapy. Front Immunol. 2023;14:1275957.","journal-title":"Front Immunol"},{"key":"8274_CR28","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3389\/fimmu.2019.00954","volume":"10","author":"EK Kleczko","year":"2019","unstructured":"Kleczko EK, Kwak JW, Schenk EL, Nemenoff RA. Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer. Front Immunol. 2019;10:954.","journal-title":"Front Immunol"},{"key":"8274_CR29","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.1007\/s00432-022-04375-6","volume":"149","author":"S Shi","year":"2023","unstructured":"Shi S, Wu T, Ma Z, Zhang X, Xu K, Tian Q, Gao L, Yin X, Xu S, Yang S. Serum-derived extracellular vesicles promote the growth and metastasis of non-small cell lung cancer by delivering the m6A methylation regulator HNRNPC through the regulation of DLGAP5. J Cancer Res Clin Oncol. 2023;149:4639\u201351.","journal-title":"J Cancer Res Clin Oncol"},{"key":"8274_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, Zhou Z, Shu G, Yin G. Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target therapy. 2022;7:3.","journal-title":"Signal Transduct Target therapy"},{"key":"8274_CR31","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H. Wnt\/\u03b2-Catenin Signaling, Disease, and Emerging Therapeutic Modalities. Cell. 2017;169:985\u201399.","journal-title":"Cell"},{"key":"8274_CR32","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/cbin.11797","volume":"46","author":"R Hayat","year":"2022","unstructured":"Hayat R, Manzoor M, Hussain A. Wnt signaling pathway: A comprehensive review. Cell Biol Int. 2022;46:863\u201377.","journal-title":"Cell Biol Int"},{"key":"8274_CR33","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers H, Nusse R. Wnt\/\u03b2-catenin signaling and disease. Cell. 2012;149:1192\u2013205.","journal-title":"Cell"},{"key":"8274_CR34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ctrv.2017.11.002","volume":"62","author":"N Krishnamurthy","year":"2018","unstructured":"Krishnamurthy N, Kurzrock R. Targeting the Wnt\/beta-catenin pathway in cancer: Update on effectors and inhibitors. Cancer Treat Rev. 2018;62:50\u201360.","journal-title":"Cancer Treat Rev"},{"key":"8274_CR35","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.chest.2019.04.114","volume":"156","author":"A Tzouvelekis","year":"2019","unstructured":"Tzouvelekis A, Gomatou G, Bouros E, Trigidou R, Tzilas V, Bouros D. Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer. Chest. 2019;156:383\u201391.","journal-title":"Chest"},{"key":"8274_CR36","doi-asserted-by":"publisher","first-page":"1250893","DOI":"10.3389\/fphar.2023.1250893","volume":"14","author":"X Shen","year":"2023","unstructured":"Shen X, Gao C, Li H, Liu C, Wang L, Li Y, Liu R, Sun C. Zhuang, Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer. Front Pharmacol. 2023;14:1250893.","journal-title":"Front Pharmacol"},{"key":"8274_CR37","doi-asserted-by":"crossref","unstructured":"Muto S, Enta A, Maruya Y, Inomata S, Yamaguchi H, Mine H, Takagi H, Ozaki Y, Watanabe M, Inoue T, Yamaura T, Fukuhara M, Okabe N, Matsumura Y, Hasegawa T, Osugi J, Hoshino M, Higuchi M, Shio Y, Hamada K, Suzuki H. Wnt\/\u03b2-catenin signaling and resistance to immune checkpoint inhibitors: from non-small-cell lung cancer to other cancers. Biomed. 2023;11.","DOI":"10.3390\/biomedicines11010190"},{"key":"8274_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1186\/s12967-024-05380-8","volume":"22","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Westover D, Tang Z, Liu Y, Sun J, Sun Y, Zhang R, Wang X, Zhou S, Hesilaiti N, Xia Q, Du Z. Wnt\/\u03b2-catenin signaling in the development and therapeutic resistance of non-small cell lung cancer. J translational Med. 2024;22:565.","journal-title":"J translational Med"},{"key":"8274_CR39","doi-asserted-by":"crossref","unstructured":"Liu GS, Li HL, Grierson D, Fu DQ. NAC transcription factor family regulation of fruit ripening and quality: a review. Cells. 2022;11.","DOI":"10.3390\/cells11030525"},{"key":"8274_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nrm.2016.8","volume":"17","author":"K Takahashi","year":"2016","unstructured":"Takahashi K, Yamanaka S. A decade of transcription factor-mediated reprogramming to pluripotency. Nat Rev Mol Cell Biol. 2016;17:183\u201393.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8274_CR41","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1002\/jcb.25605","volume":"117","author":"KA Papavassiliou","year":"2016","unstructured":"Papavassiliou KA, Papavassiliou AG. Transcription Factor Drug Targets. J Cell Biochem. 2016;117:2693\u20136.","journal-title":"J Cell Biochem"},{"key":"8274_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/ijmm.2013.1367","volume":"32","author":"Y Tabuchi","year":"2013","unstructured":"Tabuchi Y, Kondo T. Targeting heat shock transcription factor 1 for novel hyperthermia therapy (review). Int J Mol Med. 2013;32:3\u20138.","journal-title":"Int J Mol Med"},{"key":"8274_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.blre.2016.07.002","volume":"31","author":"ME Daly","year":"2017","unstructured":"Daly ME. Transcription factor defects causing platelet disorders. Blood Rev. 2017;31:1\u201310.","journal-title":"Blood Rev"},{"key":"8274_CR44","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0959-440X(02)00314-7","volume":"12","author":"SK Burley","year":"2002","unstructured":"Burley SK, Kamada K. Transcription factor complexes. Curr Opin Struct Biol. 2002;12:225\u201330.","journal-title":"Curr Opin Struct Biol"},{"key":"8274_CR45","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.tplants.2023.11.022","volume":"29","author":"F Gao","year":"2024","unstructured":"Gao F, Dubos C. The arabidopsis bHLH transcription factor family. Trends Plant Sci. 2024;29:668\u201380.","journal-title":"Trends Plant Sci"},{"key":"8274_CR46","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/15548627.2022.2062112","volume":"19","author":"Y Xu","year":"2023","unstructured":"Xu Y, Wan W. Acetylation in the regulation of autophagy. Autophagy. 2023;19:379\u201387.","journal-title":"Autophagy"},{"key":"8274_CR47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41573-022-00571-8","volume":"22","author":"O Hassin","year":"2023","unstructured":"Hassin O, Oren M. Drugging p53 in cancer: one protein, many targets, Nature reviews. Drug discovery. 2023;22:127\u201344.","journal-title":"Drug discovery"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08274-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08274-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08274-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:12:53Z","timestamp":1785517973000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08274-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8274"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08274-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"5 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical treatment of the animals was ensured throughout the experiment by adhering to the protocols authorized by the Institutional Animal Care and Use Committee (IACUC). The xenograft assays were approved by the Committee on Animal Welfare of Tangdu Hospital, Air Force Medical University. This study was conducted in accordance with the ARRIVE guidelines (\n                      \n                      ) to ensure the highest standards of animal welfare and reporting. Clinical trial number: not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest regarding the publication of this paper.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"967"}}